-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On the 16th, Zejing Pharmaceutical issued an announcement stating that Donafinil Tosylate Tablets is a multi-center, randomized, double-blind, placebo-controlled treatment of locally advanced/metastatic radioiodine refractory differentiated thyroid cancer (RAIR-DTC) The Phase III clinical trial (code name: ZGDD3) carried out a preset interim analysis, and the Independent Data Monitoring Committee (IDMC) reviewed the results and determined that the effectiveness and safety results were in line with expectations
After communicating with the Drug Evaluation Center of the National Medical Products Administration, the company has obtained CDE's approval to terminate the ZGDD3 trial ahead of schedule.